Related Experiment Video
Updated: Apr 22, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Effect of EHR user interface changes on internal prescription discrepancies
A Turchin1, A Sawarkar2, Y A Dementieva3
1Harvard Clinical Research Institute , Boston, MA ; Division of Endocrinology, Brigham and Women's Hospital , Boston, MA ; Harvard Medical School , Boston, MA.
Objective:
To determine whether specific design interventions (changes in the user interface (UI)) of an electronic health record (EHR) medication module are associated with an increase or decrease in the incidence of contradictions between the structured and narrative components of electronic prescriptions (internal prescription discrepancies).
Materials And Methods:
We performed a retrospective analysis of 960,000 randomly selected electronic prescriptions generated in a single EHR between 01/2004 and 12/2011. Internal prescription discrepancies were identified using a validated natural language processing tool with recall of 76% and precision of 84%. A multivariable autoregressive integrated moving average (ARIMA) model was used to evaluate the effect of five UI changes in the EHR medication module on incidence of internal prescription discrepancies.
Results:
Over the study period 175,725 (18.4%) prescriptions were found to have internal discrepancies. The highest rate of prescription discrepancies was observed in March 2006 (22.5%) and the lowest in March 2009 (15.0%). Addition of "as directed" option to the
Conclusions:
Several UI changes in the electronic medication module were effective in reducing the incidence of internal prescription discrepancies. Further research is needed to identify interventions that can completely eliminate this type of prescription error and their effects on patient outcomes.
More Related Videos
Related Concept Videos
Methods of Documentation VII: EMR
Drug Dosing: Geriatric Patients
Modified-Release Drug Delivery Systems: Overview
Factors Affecting Drug Response: Overview
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Dosage Regimen: Individualization

